Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. van Ommen-Nijhof A, Jacobse JN, Steggink LC, Lefrandt JD, et al. Breast Cancer Res Treat 2022 Oct 1. pii: 10.1007/s10549-022-06714.

Read + Share

Amedeo Smart

Independent Medical Education

van Ommen-Nijhof A, Jacobse JN, Steggink LC, Lefrandt JD, et al. Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors. Breast Cancer Res Treat 2022 Oct 1. pii: 10.1007/s10549-022-06714.
PMID: 36181605